News

crypto

Find us here ...

Subscribe to our newsletter

The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS

The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.

No spam - just the good stuff

More

News

crypto

VitaDAO and GlycanAge explore longevity and DeSci in Abu Dhabi event

Ending Age-Related Diseases conference looks to future of longevity

VitaDAO launches VITA-FAST tokens building on 2000% initial oversubscription

It’s a brave new world – but longevity needs to stay in the realm of the credible

ImmuneAGE Bio lands $50,000 from VitaDAO to advance research on immune system rejuvenation

Zuzalu: a pop-up city with longevity at its heart

King’s College and the LSF partner to advance human longevity education and research

VitaDAO closes $4.1 million fundraising round

Longevity Campaign will crowdfund better aging for all

Find us here ...

Subscribe to our newsletter

More